查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球自動輸液系統市場
市場調查報告書
商品編碼
1296897

2023-2030年全球自動輸液系統市場

Global Autotransfusion Systems Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

由於人們對血液短缺和輸血安全越來越關注，自體輸血的意義越來越大。隨著血液保存方法、輸血醫學、血液成分分離技術的進步，以及臨床需求的不斷成長，ABT技術的範圍得到了很大程度的擴大和創新。在器官移植手術中，對失血的管理有很大的需求。因此，自體輸血被作為一種策略來利用，以減少異體輸血的有害影響的發生。採用這種方法是為了避免極端使用捐贈的血液。

術前自體輸血包括收集病人的血液並儲存一段時間。由於肝臟移植沒有確定的日期，不包括涉及活體捐贈者的病例，提前採血通常是不可行的。因此，術中搶救性自體輸血（IBSA）被作為自體輸血的一種策略。 IBSA包括在手術過程中回收損失的血液，並通過輸血將其送回病人體內。這消除了對異體輸血的需要，因為異體輸血可能會對受血者的生存產生影響，並產生免疫抑製作用。異體輸血增加了病毒感染的傳播和病人之間輸血錯誤的風險。這反過來又促進了器官移植手術中對自動輸血系統的需求，以管理失血，提高手術中的安全性和有效性。

目錄

第一章：報告摘要

  • 當前行業分析和成長潛力展望
  • 研究方法和工具
  • 市場細分
    • 按領域分類
    • 按地區

第二章：市場概述和洞察力

  • 報告的範圍
  • 分析師的洞察力和當前的市場趨勢
    • 主要發現
    • 建議
    • 總結

第三章：競爭格局

  • 主要公司分析
  • Medtronic plc
    • 概述
    • 財務分析
    • SWOT分析
    • 近期發展情況
  • Fresenius KabiAG
    • 概況
    • 財務分析
    • SWOT分析
    • 近期發展情況
  • Becton, Dickinson& Co.
    • 進展概況
    • 財務分析
    • SWOT分析
    • 近期發展情況
  • LivaNova PLC
    • 進展概況
    • 財務分析
    • SWOT分析
    • 近期發展情況
  • B. Braun Melsungen AG
    • 進展概況
    • 財務分析
    • SWOT分析
    • 近期發展
  • 關鍵戰略分析

第四章：市場細分

  • 全球自動輸血系統的應用市場
    • 骨科手術
    • 心臟手術
    • 創傷手術
    • 器官移植
    • 其他手術
  • 按類型分類的全球自動輸血系統市場
    • 自體輸血產品
    • 輔料

第五章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第六章：公司簡介

  • Advancis Surgical
  • Atrium Medical Corp.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Co.
  • Beijing ZKSK Technology Co., Ltd.
  • BraileBiomedica
  • Brightwake Ltd.
  • Ecomed Solutions, LLC
  • Fresenius KabiAG
  • Gen World Medical Devices
  • Getinge AB
  • Haemonetics Corp.
  • LivaNova PLC
  • Medtronic plc
  • Palex Medical SA
  • RedaxS.pa
  • Sarstedt Ag & Co. KG
  • Stryker Corp.
  • Teleflex Inc.
  • Terumo Corp.
  • Zimmer Biomet Holdings, Inc.
Product Code: OMR2027369

Global autotransfusion systems market is estimated to grow at a CAGR of 5.6% during the forecast period. The major factors contributing to the market growth include the rising number of surgeries, increasing demand for organ transplantation, and emerging focus on patient blood management. The rising number of organ transplantation procedures have witnessed over the years. For instance, as per the Global Observatory on Donation and Transplantation (GODT), in 2017, the number of organs transplanted was 139,024, which increased to 7.3% over 2015. There were 16 transplants per hour in 2017. Of these, 90,306 kidney transplants and 32,348 liver transplants were performed in 2017. This rising demand for organ transplants is leading to increasing demand for autologous blood transfusion for patients' blood management during the organ transplantation procedure.

Autologous blood transfusion has been increasingly gaining significance owing to the growing concerns about blood shortage and blood transfusion safety. With the advances in blood conservation methods, blood transfusion medicine, blood component separation technology, and continuous growth in clinical needs, the scope of ABT technology has been broadened and innovated to a significant extent. There is a significant need for the management of blood loss in organ transplantation procedures. As a result, autologous transfusion is utilized as a strategy to minimize the incidence of the harmful effects of allogeneic transfusion. The method is employed to avoid the extreme use of donated blood.

Preoperative autologous transfusion involves collecting patients' blood and stored for some time. As there is no determined date for liver transplants, excluding cases that involve living donors, blood collection in advance is normally not feasible. Therefore, intraoperative blood salvage autotransfusion (IBSA) is employed as a strategy for autologous transfusion. IBSA involves the recovery of blood loss during the procedure and returns it to the patient's body by infusion. This eliminates the need for an allogeneic blood transfusion which may have an impact on recipient survival and an immunosuppressive effect. Allogeneic transfusion increases the risk of transmission of viral infections and transfusion errors among patients. This, in turn, is contributing to the demand for autotransfusion systems in organ transplant procedures to manage blood loss and increase safety and effectiveness during the procedure.

Segmental Outlook

The global autotransfusion systems market is segmented based on application and type. Based on application, the market is classified into orthopedic surgery, cardiac surgery, trauma procedures, organ transplantation, and other procedures. Based on type, the market is classified into autotransfusion products and accessories.

Cardiac surgeries held a significant share of the application segment

The rising number of cardiac surgeries coupled with significant blood loss during the procedure is primarily strengthening the demand for autotransfusion systems in cardiac surgeries. Autologous transfusion is an easy valuable concept to save blood and minimize the transfusion requirement in the postoperative period in cardiopulmonary bypass and open-heart surgeries. It minimizes the requirement for allogeneic blood products in adult cardiac surgery. Preoperative autologous is a safe and efficient option for allogeneic transfusion. Patients suffering from rare blood phenotypes or allogeneic antibodies is expected to benefit from autologous transfusion as compatible allogeneic blood may not be always available.

Allogeneic transfusion is associated with potential complications that can be removed or reduced while autologous blood is administered. These complications include alloimmunization, transfusion-transmitted infectious diseases, hemolytic reactions, and allergic and febrile reactions. The withdrawal of autologous blood earlier conducting cardiopulmonary bypass preserves red cell mass protects the platelets, and decreases allogeneic transfusion needs. The appropriate condition for autologous blood donation is elective cardiac surgery where there is a high probability of blood transfusion.

Regional Outlook

The global autotransfusion systems market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. North America has witnessed potential in the market owing to the increasing prevalence of chronic diseases, including CVD and cancer, and significant blood management programs in the programs. Several universities and hospitals have focused on blood management programs to maintain safety and efficiency in the procedure. For instance, in 2010, Mayo Clinic implemented a patient blood-management program and has since experienced a 35%decrease in blood transfusions, increasing patient outcomes and achieving considerable savings. This, in turn, is contributing to the demand for autotransfusion systems to reduce the need for donated blood and eliminates the detrimental effects of allogeneic transfusion.

Asia-Pacific is expected to witness significant growth during the forecast period

Asia-Pacific is estimated to show significant growth during the forecast period owing to the increasing number of multi-specialty hospitals and rising incidences of orthopedic and CVD in the region. In addition, growing medical tourism is expected to offer an opportunity for market growth in the region. India Brand Equity Foundation (IBEF) estimated that the medical tourism market in India was valued at $3 billion in 2017. During the period, 2018-2019, the Indian medical tourism market is expected to double owing to the easier norms for medical visa approvals. The number of Foreign Tourist Arrivals (FTAs) in India on medical visas increased by 15.9% year-on-year to an estimated 495,056 in 2017 from 427,014 in 2016.

In India, the Joint Commission International (JCI) - accredited hospitals are 21 and are growing significantly. The presence of skilled pediatric experts in India is further attributed to the positive demand for the congenital heart disease market. As per Indian Pediatrics, currently, India has approximately 130 pediatric cardiologists and 110 pediatric cardiac surgeons. As a large number of infants are born with congenital heart defects globally, the availability of skilled cardiac surgeons and cost-effective and reliable treatment is estimated to contribute to the growth of medical tourism in the country. This, in turn, is encouraging hospitals to focus on patient safety and thereby contributing to the demand for autotransfusion systems to manage patients' blood.

Market Players Outlook

The major players in the market include Medtronic plc, Fresenius Kabi AG, Becton, Dickinson & Co., LivaNova PLC, and B. Braun Melsungen AG. The market players are adopting strategies such as mergers and acquisitions and product launches, to expand market share and gain a competitive advantage over their competitors. For instance, in April 2019, Ecomed Solutions launched HEMAsavR, a device for blood capture and transfer that will support medical professionals decrease complex and costly allogeneic blood transfusions. It is universally compatible with surgical suction and autologous transfusion systems, which makes it easy to integrate into current protocols. It is primarily beneficial to hospitals that perform orthopedic, cardiac, vascular, trauma, organ transplant, obstetrics/gynecology, thoracic, neurosurgery, general, and urology procedures.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Medtronic plc
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Fresenius KabiAG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Becton, Dickinson& Co.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. LivaNova PLC
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. B. Braun Melsungen AG
    • 3.6.1. Overview
    • 3.6.2. Financial Analysis
    • 3.6.3. SWOT Analysis
    • 3.6.4. Recent Developments
  • 3.7. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Autotransfusion Systems Market by Application
    • 4.1.1. Orthopedic Surgery
    • 4.1.2. Cardiac Surgery
    • 4.1.3. Trauma Procedures
    • 4.1.4. Organ Transplantation
    • 4.1.5. Other Procedures
  • 4.2. Global Autotransfusion Systems Market by Type
    • 4.2.1. Autotransfusion Products
    • 4.2.2. Accessories

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Advancis Surgical
  • 6.2. Atrium Medical Corp.
  • 6.3. B. Braun Melsungen AG
  • 6.4. Becton, Dickinson and Co.
  • 6.5. Beijing ZKSK Technology Co., Ltd.
  • 6.6. BraileBiomedica
  • 6.7. Brightwake Ltd.
  • 6.8. Ecomed Solutions, LLC
  • 6.9. Fresenius KabiAG
  • 6.10. Gen World Medical Devices
  • 6.11. Getinge AB
  • 6.12. Haemonetics Corp.
  • 6.13. LivaNova PLC
  • 6.14. Medtronic plc
  • 6.15. Palex Medical SA
  • 6.16. RedaxS.p.a.
  • 6.17. Sarstedt Ag & Co. KG
  • 6.18. Stryker Corp.
  • 6.19. Teleflex Inc.
  • 6.20. Terumo Corp.
  • 6.21. Zimmer Biomet Holdings, Inc.

LIST OF TABLES

  • 1. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 2. GLOBAL AUTOTRANSFUSION SYSTEMS IN ORTHOPEDIC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL AUTOTRANSFUSION SYSTEMS IN CARDIAC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL AUTOTRANSFUSION SYSTEMS IN TRAUMA PROCEDURES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL AUTOTRANSFUSION SYSTEMS IN ORGAN TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL AUTOTRANSFUSION SYSTEMS IN OTHER PROCEDURES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 8. GLOBAL AUTOTRANSFUSION PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL AUTOTRANSFUSION ACCESSORIES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2022-2030 ($ MILLION)
  • 10. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 14. EUROPEAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. EUROPEAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 16. EUROPEAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. ASIA-PACIFIC AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 19. ASIA-PACIFIC AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 2. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 3. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL AUTOTRANSFUSION SYSTEMS IN ORTHOPEDIC SURGERY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL AUTOTRANSFUSION SYSTEMS IN CARDIAC SURGERY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL AUTOTRANSFUSION SYSTEMS IN TRAUMA PROCEDURES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL AUTOTRANSFUSION SYSTEMS IN ORGAN TRANSPLANTATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL AUTOTRANSFUSION SYSTEMS IN OTHER PROCEDURES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL AUTOTRANSFUSION PRODUCTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL AUTOTRANSFUSION ACCESSORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. US AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. CANADA AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. UK AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. FRANCE AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. GERMANY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. ITALY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. SPAIN AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. ROE AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. INDIA AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CHINA AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. JAPAN AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)